Get started
Author

Andrew W. Greaves

ZAP-70 Compared with Immunoglobulin Heavy-Chain Gene Mutation Status as a Predictor of Disease Progression in Chronic Lymphocytic Leukemia
2004 · Laura Z. Rassenti, Lang Huynh, et al. · New England Journal of Medicine · 913
Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia
2008 · Laura Z. Rassenti, Sonia Jain, et al. · Blood · 326
The Dohner fluorescence in situ hybridization prognostic classification of chronic lymphocytic leukaemia ( CLL ): the CLL Research Consortium experience
2016 · Daniel L. Van Dyke, Lillian Werner, et al. · British Journal of Haematology · 78
PDF
Use of IGHV3–21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post–germinal center leukemogenic selection
2008 · Emanuela M. Ghia, Sonia Jain, et al. · Blood · 73
PDF
Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia
2014 · Rainer Claus, David M. Lucas, et al. · Blood · 70
Lenalidomide and Rituximab for the Initial Treatment of Patients With Chronic Lymphocytic Leukemia: A Multicenter Clinical-Translational Study From the Chronic Lymphocytic Leukemia Research Consortium
2014 · Danelle F. James, Lillian Werner, et al. · Journal of Clinical Oncology · 66
Stimulation of chronic lymphocytic leukemia cells with CpG oligodeoxynucleotide gives consistent karyotypic results among laboratories: a CLL Research Consortium (CRC) Study
2010 · Nyla A. Heerema, John C. Byrd, et al. · Cancer Genetics and Cytogenetics · 52
Standardization of fluorescence in situ hybridization studies on chronic lymphocytic leukemia (CLL) blood and marrow cells by the CLL Research Consortium
2010 · Stephanie A. Smoley, Daniel L. Van Dyke, et al. · Cancer Genetics and Cytogenetics · 24
Cyclic nucleotide phosphodiesterase 7B mRNA: An unfavorable characteristic in chronic lymphocytic leukemia
2010 · Lingzhi Zhang, Fiona Murray, et al. · International Journal of Cancer · 20
Self‐administered, subcutaneous alemtuzumab to treat residual disease in patients with chronic lymphocytic leukemia
2010 · William G. Wierda, Thomas J. Kipps, et al. · Cancer · 20
PDF
Supporting the design of translational clinical studies through the generation and verification of conceptual knowledge-anchored hypotheses.
2008 · Philip R O Payne, Philip Richard Orrin Payne, et al. · PubMed · 15
CRC Clinical Trials Management System (CTMS): an integrated information management solution for collaborative clinical research.
2003 · Philip R O Payne, Andrew W Greaves, et al. · PubMed · 15
Lenalidomide and Rituximab for the Initial Treatment of Patients with Chronic Lymphocytic Leukemia (CLL) A Multicenter Study of the CLL Research Consortium
2011 · Danelle F. James, Jennifer R. Brown, et al. · Blood · 12
Ontology-anchored Approaches to Conceptual Knowledge Discovery in a Multi-dimensional Research Data Repository.
2008 · Philip R O Payne, Tara B Borlawsky, et al. · PubMed · 12
Phenotypic Changes Associated with Acute Reductions In Leukemia Cell Counts In Patients with Chronic Lymphocytic Leukemia (CLL) Receiving Lenalidomide as Initial Therapy
2010 · Danelle F. James, Jennifer R Brown, et al. · Blood · 4
CRC Tissue Core Management System (TCMS): integration of basic science and clinical data for translational research.
2003 · Andrew W Greaves, Philip R Payne, et al. · PubMed · 4
Population-Based Evaluation of Postacute Coronavirus Disease-2019 (COVID-19) Chronic Sequelae in Patients Who Tested Positive for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
2022 · Nicole H Goldhaber, W Scott Ogan, et al. · Open Forum Infectious Diseases · 3
PDF
Kinetic Measurement of Leukemia-Cell Proliferation Rate By Deuterium Labeling Predicts Time to Initial Treatment of Patients with Chronic Lymphocytic Leukemia
2014 · Elizabeth J Murphy, Donna Neuberg, et al. · Blood · 3
The TRITON Project: Design and Implementation of an Integrative Translational Research Information Management Platform.
2010 · Philip R O Payne, Tara B Borlawsky, et al. · PubMed · 3
Lenalidomide Administered for the Initial Treatment of Chronic Lymphocytic Leukemia (CLL) Patients- In Vivo Modulation of the Leukemia Cell Surface Phenotype and Association with Tumor Flare Reaction (TFR).
2009 · Danelle James, Esther D Avery, et al. · Blood · 3
Characteristics of Familial CLL Evaluated in the CLL Research Consortium Cohort
2008 · Jennifer R Brown, Laura Rassenti, et al. · Blood · 2
Relative Value of CD38 and ZAP-70 Versus Immunoglobulin Mutation Status in Predicting Early Disease Progression in Chronic Lymphocytic Leukemia.
2006 · Laura Z. Rassenti, Donna S. Neuberg, et al. · Blood · 2
The Relative Significance of ZAP-70 Promoter Methylation As a Prognostic Factor in Previously Untreated Chronic Lymphocytic Leukemia: Validation of Results Using a Second Large CLL Research Consortium (CRC) Patient Data Set
2012 · Rainer Claus, Amy S. Ruppert, et al. · Blood
Karyotype Results From CpG Oligodeoxynucleotide Stimulated Chronic Lymphocytic Leukemia (CLL) Cultures Are Consistent Among Laboratories: a CLL Research Consortium (CRC) Study.
2009 · Nyla A. Heerema, John C. Byrd, et al. · Blood
Validation of CLL FISH Panel Scoring by Members of the Chronic Lymphocytic Leukemia Research Consortium.
2008 · Stephanie A. Smoley, Daniel L. Van Dyke, et al. · Blood
Works count: 32
Citation count: 1,735
H-index: 13
I10-index: 15
Year
Topic
Type